Nectar Life Sciences, Inc. — Form D
Nectar Life Sciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-02. The offering totals $24.3M, of which $24.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-12-02
- Form: D
- Accession: 0001895449-22-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $24.3M
- Amount sold: $24.3M
- Investors: 11
- Date of first sale: 2022-11-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466370
Issuer
- Name: Nectar Life Sciences, Inc.
- CIK: 0001895449
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 30 COOPER SQUARE, NEW YORK, NY, 10003
- Phone: 000-000-0000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ken Chahine | Director | New York, NY |
| PATRICK CHUN | Director | ST. PAUL, MN |
| James Joaquin | Director | LAKE ELMO, MN |
| Mark Lotke | Director | New York, NY |
| Ken Chahine | Executive Officer | New York, NY |
More